|
0
|
|
Minimal supply chain and forecasting testing volumes for clinical bacteriology laboratories in resource-limited settings for individual patient care: a costing study.
(linkinghub.elsevier.com)
|
Semret M
…
Yansouni CP
Lancet Microbe
2027 Jul 23
|
#diagnostics
#bacteriology
#sepsis
#resource-limited
#amr
|
|
0
|
|
In vitro activity of zoliflodacin against Neisseria gonorrhoeae collected in the United States from 2020 to 2022.
(journals.asm.org)
|
McLeod SM
…
Daram P
Antimicrobial Agents and Chemotherapy
2026-08-03
|
#amr
#gonorrhea
#susceptibility
|
|
0
|
|
Making microbes matter: evidence for the use of digital storytelling in antimicrobial resistance public engagement.
(nature.com)
|
McCall B
…
Shallcross L
npj Antimicrobials and Resistance
2026-08-03
|
#amr
#public-engagement
#health-communication
#behavior change
|
|
0
|
|
Carbapenemase-producing Klebsiella oxytoca complex in France (2017-2023): Molecular epidemiology integrated with virulence and biofilm phenotypes.
(tandfonline.com)
|
Rezzoug I
…
Dortet L
Emerging Microbes & Infections
2026-08-03
|
#amr
#biofilm
#virulence
#epidemiology
#sequencing
|
|
0
|
|
Nonantibiotic-driven evolution reveals rare but predictable routes to broad antibiotic resistance.
(journals.asm.org)
|
Li C
…
Mitchell A
mBio
2026-08-03
|
#amr
#evolution
#microbiome
|
|
0
|
|
Screening for multi-drug resistance carriage and appropriate initial antibiotic treatment of ICU-acquired bloodstream infections.
(linkinghub.elsevier.com)
|
Hassoun-Kheir N
…
Buetti N
Clinical Microbiology and Infection
2026-08-03
|
#infection
#amr
#screening
#sepsis
|
|
0
|
|
Luteolin as a urease inhibitor: A novel therapeutic strategy against Helicobacter pylori.
(tandfonline.com)
|
Wang X
…
Song W
Virulence
2026-08-03
|
#urease
#h-pylori
#amr
#metabolomics
#proteomics
|
|
0
|
|
Penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis and the association with penicillin-binding protein mutations: a population genotypic and phenotypic study.
(journals.asm.org)
|
Xie O
…
Davies MR
Antimicrobial Agents and Chemotherapy
2026-08-03
|
#amr
#sequencing
#infection
|
|
0
|
|
Computational design of antimicrobial peptide nanopores.
(nature.com)
|
Deb R
…
Vacha R
Nature Chemical Biology
2026-08-03
|
#amr
#peptide
#computational design
#membrane
|
|
0
|
|
Molecular Epidemiology and Drug Resistance of Extraintestinal Pathogenic Escherichia coli Bloodstream Isolates From Adults Worldwide (2011-2023).
(academic.oup.com)
|
de Been M
…
Weerdenburg E
Clinical Infectious Diseases
2026-08-03
|
#amr
#epidemiology
#sepsis
#bacteremia
#sequencing
|
|
0
|
|
Case Commentary: Emergence of clinically relevant fidaxomicin-resistant Clostridioides difficile strains.
(journals.asm.org)
|
Garey KW
…
Hurdle JG
Antimicrobial Agents and Chemotherapy
2026-08-03
|
#amr
#cdi
#infection
#antibiotic
#surveillance
|
|
0
|
|
Resistance development in KPC-producing Klebsiella pneumoniae under ceftazidime/avibactam-meropenem pressure: KPC-2 Omega-loop mutations attenuate avibactam efficacy.
(journals.asm.org)
|
Li F-H
…
Yu Y
Microbiology Spectrum
2026-08-03
|
#amr
#mutation
#klebsiella
|
|
0
|
|
Dynamic balance of CRISPR-Cas immunity and resistance plasmid anti-immunity mediated by a bifunctional protein AcrIE10.
(nature.com)
|
Tsui W
…
Wang M
Nature Communications
2026-08-03
|
#amr
#crispr
#plasmids
#immunity
#protein-protein interaction
|